May 4, 2023 01:34 PM EDTUpdated May 8, 12:26 PM
Pharma
FDA+

FDA hits No­vo Nordisk with CRL for its once-dai­ly he­mo­phil­ia drug con­cizum­ab

Katherine Lewin

News Reporter

No­vo Nordisk had to find a “new path for­ward” for its he­mo­phil­ia A and B drug back in 2020 af­ter halt­ing sev­er­al stud­ies be­cause of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Ver­sant un­veils Light Horse with $62M and a part­ner­ship with No­var­tis

Af­ter lack­lus­ter 2024, bio­phar­ma in­dus­try prays stalled M&A will fi­nal­ly move in­to gear

IGM Bio­sciences’ au­toim­mune piv­ot lasts three months af­ter in­ter­im da­ta dis­ap­point

Shore­line cuts staff as its part­ner­ship with Gilead­'s Kite is now in flux

Ex­clu­sive: First-of-its-kind in­fant DNA ed­it leads to ap­par­ent cure in dis­ease that set back field 25 years ago

Aio­los team re­unites with $411M for new biotech with obe­si­ty drugs from Chi­na

A service from the Financial Times